Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGFα and epiregulin in androgen-independent prostate cancer cell lines

被引:0
|
作者
Torring, N
Jorgensen, PE
Sorensen, BS
Nexo, E
机构
[1] Aarhus Univ Hosp, AKH, Dept Clin Biochem, DK-8000 Aarhus C, Denmark
[2] Viborg Hosp, Dept Clin Biochem, Viborg, Denmark
关键词
epidermal growth factor; epiregulin; prostate cancer; cell lines; ELISA; RT-PCR;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The proliferation of androgen-independent prostate cancer cell lines has previously been shown to be influenced by an autocrine loop of the epidermal growth factor (EGF) system. This observation has alerted us to study the expression of ligands and receptors from the ECF-system in prostate cell lines. Methods. The expression of the EGF system was determined by quantitative RT-PCR and ELISA in the normal prostate epithelial cell line (PNT1A), in the androgen sensitive- (LNCaP), and the androgen-independent (DU145 and PC3) prostate cancer cell lines. Results. The expression of mRNA for the ligands TGF alpha, amphiregulin, HB-EGF and epiregulin were increased 10 to 100 fold in androgen-independent cells, as compared to LNCaP and PNT1A cells. Expression of mRNA for the ligands EGF and betacellulin and of the receptors HER1 and HER2 were similar in all lines investigated except LNCaP cells which exhibit low expression of HER1. Similar results were obtained by ELISA. Conclusions. The data indicates a selective up-regulation of a subclass of ligands of the EGF-system in androgen-independent prostate cancer cell lines. We suggest this could be a mechanism to escape androgen dependence in prostate cancer.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [21] Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinase
    Su, Yanwei
    Besner, Gail E.
    JOURNAL OF SURGICAL RESEARCH, 2014, 189 (02) : 222 - 231
  • [22] Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: A potential paracrine role during implantation
    Lessey, BA
    Gui, YT
    Apparao, KBC
    Young, SL
    Mulholland, J
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2002, 62 (04) : 446 - 455
  • [23] High-Level Expression and Purification of Heparin-Binding Epidermal Growth Factor (HB-EGF) with SUMO Fusion
    Wuguang Lu
    Peng Cao
    Huangzong Lei
    Shuangquan Zhang
    Molecular Biotechnology, 2010, 44 : 198 - 203
  • [24] High-Level Expression and Purification of Heparin-Binding Epidermal Growth Factor (HB-EGF) with SUMO Fusion
    Lu, Wuguang
    Cao, Peng
    Lei, Huangzong
    Zhang, Shuangquan
    MOLECULAR BIOTECHNOLOGY, 2010, 44 (03) : 198 - 203
  • [25] Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
    Gregory, CW
    Hamil, KG
    Kim, D
    Hall, SH
    Pretlow, TG
    Mohler, JL
    French, FS
    CANCER RESEARCH, 1998, 58 (24) : 5718 - 5724
  • [26] Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines
    许克新
    王向红
    凌明达
    王云川
    中华医学杂志(英文版), 2003, (11) : 75 - 79
  • [27] cDNA cloning and gene expression of heparin-binding EGF-like growth factor (HB-EGF) in allergen-sensitized and exposed guinea pig lungs
    Shiomi, T
    Asano, K
    Oguma, T
    Fukunaga, K
    Yamaguchi, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A402 - A402
  • [28] Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines
    许克新
    王向红
    凌明达
    王云川
    ChineseMedicalJournal, 2003, (11)
  • [29] Immunohistochemical analysis of HB-EGF expression in breast, colon, gastric, hepatocellular, lung, ovarian, pancreatic and prostate cancer
    Halim, Abdel-baset
    Dauffenbach, Lisa M.
    Kerfoot, Christopher A.
    Stull, William R.
    Zwick-Wallasch, Esther
    Scheyer, Richard
    Senaldi, Giorgio
    CANCER RESEARCH, 2011, 71
  • [30] Androgen receptor expression in androgen independent prostate cancer cell lines
    Chlenski, A
    Nakashiro, K
    Ketels, KV
    Korovaitseva, GI
    Oyasu, R
    PROSTATE, 2001, 47 (01): : 66 - 75